Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Morrison to Disease Progression

This is a "connection" page, showing publications David Morrison has written about Disease Progression.

 
Connection Strength
 
 
 
0.141
 
  1. Morrison D, Shaffer J, Ying GS, Binenbaum G. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. J AAPOS. 2018 04; 22(2):128-133.
    View in: PubMed
    Score: 0.078
  2. Cavuoto KM, Trivedi RH, Prakalapakorn SG, Oatts JT, Nallasamy S, Morrison DG, Pineles SL, Chang MY. Multifocal Soft Contact Lenses for the Treatment of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025 04; 132(4):495-503.
    View in: PubMed
    Score: 0.031
  3. Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018 12 01; 136(12):1383-1389.
    View in: PubMed
    Score: 0.020
  4. Law JC, Recchia FM, Morrison DG, Donahue SP, Estes RL. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS. 2010 Feb; 14(1):6-10.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)